Cibus, Inc.

NASDAQ:CBUS

Biotechnology

Healthcare
$1.23 +3.10%

+$0.04 today

Market cap
$94.01M
Beta
1.65
P/E (TTM)
-8.6
EPS (TTM)
-$0.16
52W Low $1.09High $4.19

Volume 0.19M

Average 0.51M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$50.59M

FY 2025 · Annual

Investing Cash Flow

-$578,000.00

FY 2025 · Annual

Financing Cash Flow

$46.65M

FY 2025 · Annual

+14.9% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(29.2M)(16.89M)(267.63M)(282.71M)(127.09M)
Depreciation & Amortization2.34M1.53M4.69M6.86M5.92M
Deferred Income Tax00000
Stock-Based Compensation2.09M4M16.09M10.75M8.19M
Change in Working Capital7.49M(2.89M)961K383K2.32M
Accounts Receivables4.89M01.7M(512K)538K
Inventory1.38M0000
Accounts Payables(360K)(229K)2K(188K)720K
Other Working Capital1.58M(2.66M)(745K)1.08M1.06M
Other Non-Cash Items(1.53M)(5.12M)215.76M206.68M60.06M
Operating Cash Flow(18.81M)(19.36M)(46.21M)(58.04M)(50.59M)
Capital Expenditures(497K)(1.52M)(4.32M)(808K)(578K)
Acquisitions (Net)0059.38M00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities11.7M0000
Investing Cash Flow11.2M(1.52M)55.06M(808K)(578K)
Debt Repayment(364K)(376K)(194K)(879K)(1.11M)
Common Stock Issued4.38M11.54M18.76M43.9M47.9M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(274K)(1.17M)1.76M(2.43M)(142K)
Financing Cash Flow3.74M9.99M20.32M40.6M46.65M
Effect of Forex Changes498K99K3K(13K)11K
Net Change in Cash(3.87M)(10.9M)29.17M(18.27M)(4.51M)
Free Cash Flow(19.31M)(20.88M)(50.53M)(58.85M)(51.17M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$127.1M
+ D&A$5.9M
+ Stock-Based Comp$8.2M
+ Deferred Tax$0
+ Working Capital$2.3M
+ Other Non-Cash$60.1M
= Operating Cash Flow-$50.6M
- Capex-$578.0K
= Free Cash Flow-$51.2M

Analysis

FY2025 free cash flow is -$51.2M. FCF conversion is 40.3% of net income. Operating cash flow was -$50.6M, with capex of -$578.0K. The largest bridge item is Other Non-Cash at $60.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 13, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026

Does CBUS generate free cash flow?

Cibus, Inc. (CBUS) generated -$51.17M of free cash flow in fiscal 2025.

How much operating cash flow does CBUS produce?

Operating cash flow was -$50.59M, before capital expenditures of $578,000.00.